Skip to main content

VZV-containing vaccines and hospitalization for herpes zoster: careful optimism

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Hope-Simpson RE (1965) The Nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 58:9–20

    CAS  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Garnett GP, Grenfell BT (1992) The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster. Epidemiol Infect 108:513–528

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Brisson M, Gay NJ, Edmunds WJ, Andrews NJ (2002) Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 20:2500–2507

    Article  CAS  PubMed  Google Scholar 

  4. 4.

    Ogunjimi B, Van Damme P, Beutels P (2013) Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review. PLoS One 8:e66485. https://doi.org/10.1371/journal.pone.0066485

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Gershon AA (2017) Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future? J Infect 74:S27–S33. https://doi.org/10.1016/s0163-4453(17)30188-3

    Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Ogunjimi B, Van den Bergh J, Meysman P (2017) Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox. Sci Rep. https://doi.org/10.1038/s41598-017-01024-8

    Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Harder T, Siedler A (2018) Systematic review and meta-analysis of chickenpox vaccination and risk of herpes zoster a quantitative view on the exogenous boosting hypothesis. Clin Infect Dis Off Publ Infect Dis Soc Am 9:9. https://doi.org/10.1093/cid/ciy1099

    Article  Google Scholar 

  8. 8.

    Pham MA, Bednarczyk RA, Becker ER, Orenstein WA, Omer SB (2019) Trends in US community hospitalizations due to herpes zoster: 2001–2015. Vaccine 37:882–888. https://doi.org/10.1016/j.vaccine.2018.12.034

    Article  PubMed  Google Scholar 

  9. 9.

    Hales CM, Harpaz R, Joesoef MR, Bialek SR (2013) Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med 159:739. https://doi.org/10.7326/0003-4819-159-11-201312030-00006

    Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Kawai K, Yawn BP, Wollan P, Harpaz R (2016) Increasing incidence of herpes zoster over a 60-year period from a population-based study. Clin Infect Dis 63:221–226

    Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Yawn BP, Itzler RF, Wollan PC, Pellissier JM, Sy LS, Saddier P (2009) Health care utilization and cost burden of herpes zoster in a community population. Mayo Clin Proc 84:787–794. https://doi.org/10.1016/s0025-6196(11)60488-6

    Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    White RR, Lenhart G, Singhal PK et al (2009) Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans. Pharmacoeconomics 27:781–792. https://doi.org/10.2165/11317560-000000000-00000

    Article  PubMed  Google Scholar 

  13. 13.

    Johnson BH, Palmer L, Gatwood J, Lenhart G, Kawai K, Acosta CJ (2016) Healthcare resource utilization and costs associated with herpes zoster in the US. J Med Econ 19:928–935. https://doi.org/10.1080/13696998.2016.1187150

    Article  PubMed  Google Scholar 

  14. 14.

    Meyers JL, Madhwani S, Rausch D, Candrilli SD, Krishnarajah G, Yan S (2017) Analysis of real-world health care costs among immunocompetent patients aged 50 years or older with herpes zoster in the United States. Hum Vaccines Immunother 13:1861–1872. https://doi.org/10.1080/21645515.2017.1324373

    Article  Google Scholar 

  15. 15.

    Friesen KJ, Chateau D, Falk J, Alessi-Severini S, Bugden S (2017) Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia. BMC Infect Dis 17:69. https://doi.org/10.1186/s12879-017-2185-3

    Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    TrendWatch Chartbook 2018: Trends affecting hospitals and health systems. American Hospital Association; 2018. https://www.aha.org. Accessed 19 Apr 2019

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Elie A. Saade.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This manuscript does not report on activities requiring ethics approval, including research involving human participants or animals.

Informed consent

Not applicable; this manuscript does not report on procedures performed in studies involving human participants.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Saade, E.A., Canaday, D.H., Davidson, H.E. et al. VZV-containing vaccines and hospitalization for herpes zoster: careful optimism. Aging Clin Exp Res 31, 1347–1348 (2019). https://doi.org/10.1007/s40520-019-01264-w

Download citation